Market Tracker

09/23 5:16pm ET

Amarin Corporation PLC (NASDAQ:AMRN)

2.94
Delayed Data
As of Sep 23
 +0.24 / +8.89%
Today’s Change
1.24
Today|||52-Week Range
3.46
+55.56%
Year-to-Date
Biotech Stocks Under $5: 2 to Buy, 1 to Avoid
Sep 24 / MotleyFool.com - Paid Partner Content
Why Polaris Industries, Amarin, and VimpelCom Slumped Today
Sep 12 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close2.70
Today’s open2.67
Day’s range2.65 - 2.97
Volume4,197,034
Average volume (3 months)2,838,758
Market cap$613.9M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-159.93%
Earnings growth (this year)+17.86%
Earnings growth (next 5 years)+207.00%
Revenue growth (last year)+51.17%
P/E ratioNM
Price/Sales4.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AMRIAlbany Molecular Res...+0.03+0.19%
ARWRArrowhead Pharmaceut...-0.05-0.69%
RGNXRegenxbio Inc-0.50-3.31%
BSTCBiospecifics Technol...+1.22+2.77%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$81.6M
Annual profit (last year)-$148.8M
Net profit margin-182.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John F. Thero
SVP-
Manufacturing Operations
Derek Kalinowski
Corporate headquarters
Dublin, Dublin

Forecasts